Rehabilitation Institute of Chicago Joins Cyberkinetics' BrainGate Neural Interface System Pilot Study > Morton Cure Paralysis Fund

Research Links

Our staff has deemed the following public research links as significant and/or new findings by the global research community in the search for a cure for paralysis. You can search the database by category, keyword, name, and/or date. Keep abreast of cure research breakthroughs by signing up for our monthly research newsletter.

Please note that the research posted here is not affiliated with the MCPF unless that is specifically stated.

Rehabilitation Institute of Chicago Joins Cyberkinetics' BrainGate Neural Interface System Pilot Study

CHICAGO & FOXBOROUGH, Mass.--(BUSINESS WIRE)--Feb. 28, 2005--The Rehabilitation Institute of Chicago (RIC) and Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) (Cyberkinetics) today announced the addition of RIC as a new clinical site for the BrainGate(TM) Neural Interface System pilot study. RIC has been ranked the "Best Rehabilitation Hospital in America" by U.S. News & World Report every year since 1991.

About the BrainGate Pilot Study

Cyberkinetics received regulatory clearance from the U.S. Food and Drug Administration (FDA) in March of 2004 to study the BrainGate Neural Interface System under an Investigational Device Exemption (IDE). The first patient was enrolled through the Sargent Rehabilitation Center in Rhode Island and has successfully been able to use his thoughts and the BrainGate System to demonstrate that the System can be used to operate a computer, environmental controls and a robotic limb. These results were presented

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050228005372&newsLang=en

posted @ Monday, February 28, 2005 12:00 AM by host